Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
about
A heparin binding synthetic peptide from human HIP / RPL29 fails to specifically differentiate between anticoagulantly active and inactive species of heparinNewly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinasesBiosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding.3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains.Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function.Podocyte-specific deletion of NDST1, a key enzyme in the sulfation of heparan sulfate glycosaminoglycans, leads to abnormalities in podocyte organization in vivo.Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells.Heparin accelerates gelsolin amyloidogenesis.Heparan sulfate proteoglycans: structure, protein interactions and cell signaling.Biology of FGFRL1, the fifth fibroblast growth factor receptor.Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses.Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors.Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes.Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor.Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.Structural determinants of heparan sulphate modulation of GDNF signalling.Sulfated derivatives of Escherichia coli K5 polysaccharides as modulators of fibroblast growth factor signaling.The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex.Selective activation of TACI by syndecan-2Control of fibroblast growth factor (FGF) 7- and FGF1-induced mitogenesis and downstream signaling by distinct heparin octasaccharide motifs.Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.Novel heparan sulfate structures revealed by monoclonal antibodies.More than a biomarker: the systemic consequences of heparan sulfate fragments released during endothelial surface layer degradation (2017 Grover Conference Series).Fibroblast Growth Factor Receptors 1 and 2 Interact Differently with Heparin/Heparan Sulfate
P2860
Q21245645-2807C6AF-D3BC-4C83-BB7A-334D554EB566Q28475274-95FEE18A-E080-49B8-9EC6-1F5011EEDE7DQ31074211-B987D53B-928C-49D5-875C-B70CEA48F34FQ33230192-C74F21B3-4A2E-4BA2-BD94-1A62227E339BQ33751398-99DEAD1A-8BE0-4278-9311-95819A4C0A6DQ33897755-6BB9A82B-2498-4D70-88ED-4DF3214F6F9DQ34361094-56954C73-1DFB-4FF8-81CD-D1F58E6FEA1AQ36219228-41F4C9DD-7235-4946-899B-D306BCF0C080Q36851279-2B03408A-8CFE-438D-918F-ACA8A2C8760AQ37132636-D5CE4F85-8CF9-48F1-AEA5-A3174B9F7E77Q37590177-FFB8420A-E9C3-4499-ACC4-652F26E5A0B5Q37809766-9841493F-2EBC-46E8-AA8C-82066BDF1E0DQ38152204-7FD24214-168C-4E82-847A-0EC2AD837E19Q38290891-B9FB487D-B0CF-4E21-B846-DD795C06C69AQ38311931-2A6074F9-6FEB-4125-93C6-7D7CF5C26F26Q38320039-C50614E7-2C88-4E7E-8DAB-0976998C38B8Q38331843-806525DC-1797-41E1-9F19-54348F1CA470Q38343318-31768DFC-1F63-40E6-8374-E1E1F039F6A6Q38418286-2B809B0D-AF0B-45CF-8FF1-4A964F090220Q39240834-159F2B9D-EC6F-4357-A953-D220349C24FFQ40601795-373B0C1F-7C9A-4D40-BA2A-A1562C4BFA6DQ40630770-45E2CD07-2F89-452D-8339-2B06CA204D48Q40668417-5956A277-EC9D-47A3-BB8A-C70C068FB380Q42193929-2ECEDF66-B3A4-4F7F-9C64-F0D6DBD45DB6Q42801360-BC94D370-BEE2-45D8-9D73-AA56340BADD3Q43640409-2AA8A28C-D43A-4705-A1C6-E1B5C8B1AC3BQ46391304-F5AAB576-0514-4B57-92FF-6C65F57625D2Q47143359-0516786A-2DC6-4A5F-ACBA-2F6FD4FB2270Q58377532-630A341A-F0B0-40E7-9D95-7437BFBF4C35
P2860
Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
@en
type
label
Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
@en
prefLabel
Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
@en
P2093
P2860
P356
P1476
Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
@en
P2093
P2860
P304
16868-16876
P356
10.1074/JBC.M011226200
P407
P50
P577
2001-02-21T00:00:00Z